Filing Details

Accession Number:
0001179022-19-000021
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-30 17:31:04
Reporting Period:
2019-01-28
Accepted Time:
2019-01-30 17:31:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1694903 E Richard Uihlein 12575 Uline Drive
Pleasant Prairie WI 53158
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-28 3,000 $4.77 2,538,289 No 4 P Direct
Common Stock Acquisiton 2019-01-29 48,500 $4.87 2,586,789 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect By Ed Uihlein Family Foundation
Footnotes
  1. The shares were sold in multiple transactions at prices ranging from $4.77 to $4.78. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  2. The shares were sold in multiple transactions at prices ranging from $4.75 to $5.00. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  3. The reporting person is president and director of Ed Uihein Family Foundation, a not-for-profit corporation. The reportion person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for purposes of Section 13(d) of the Securities Exchange Act of 1934.